
Seelos Therapeutics Inc
NASDAQ:SEEL

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SEEL's stock price target?
Not Available
SEEL doesn't have any price targets made by Wall Street professionals.
What is Seelos Therapeutics Inc's Revenue forecast?
Projected CAGR
263%
For the last 8 years the
compound annual growth rate for
Seelos Therapeutics Inc's revenue is
-9%.
The projected
CAGR
for the next 2 years is
263%.